Health Canada GPP is modelled on pharmaceutical cGMP. FDA applies existing drug regulations to cannabis products making therapeutic claims. GMPify delivers the training your quality team needs - built from 27 years of pharmaceutical GMP training experience.
Health Canada conducts GMP-style inspections of every licensed cannabis producer in Canada. The inspection findings mirror pharmaceutical 483 observations almost exactly.
In the US, any cannabis product making therapeutic claims falls under FDA drug regulations. State-level adult-use markets are progressively tightening quality standards toward pharmaceutical-grade requirements.
The regulatory direction is unambiguous. The training gap is enormous. Most cannabis quality teams have never worked in a pharmaceutical environment and have no framework for understanding what cGMP compliance actually requires.
Health Canada's Good Production Practices under the Cannabis Regulations are explicitly modelled on pharmaceutical cGMP. The core quality system obligations are identical.
Quality unit independence. Written procedures. Batch record requirements. Deviation investigation. CAPA. Change control. Supplier qualification. Data integrity.
Every GMPify course that covers these topics applies directly to cannabis manufacturing.
The requirements are not just similar. They are derived from the same regulatory framework.
| Requirement | Health Canada GPP | FDA 21 CFR 211 | GMPify courses cover this |
|---|---|---|---|
| Quality unit independence | Required | 21 CFR 211.22 | Yes |
| Written procedures and SOPs | Required | 21 CFR 211.100 | Yes |
| Batch record requirements | Required | 21 CFR 211.188 | Yes |
| Deviation investigation | Required | 21 CFR 211.192 | Yes |
| CAPA programme | Required | 21 CFR 211.192 | Yes |
| Laboratory controls and OOS | Required | 21 CFR 211.160 | Yes |
| Data integrity | Required | 21 CFR Part 11 | Yes |
| Supplier qualification | Required | 21 CFR 211.84 | Yes |
| Contract manufacturing oversight | Required | 21 CFR 211.22 | Yes |
| Annual product quality review | Required | 21 CFR 211.180(e) | Yes |
Every course below covers requirements that Health Canada GPP and FDA apply to cannabis manufacturers.
What cGMP is, why it exists, how the quality unit works and what an inspection looks like. The starting point for every cannabis quality professional.
ALCOA+ principles, audit trail requirements, electronic record controls and the data integrity violations Health Canada and FDA consistently cite in cannabis operations.
The complete two-phase investigation framework covering scope determination, root cause analysis, CAPA structure and effectiveness criteria. The number one inspection finding in both cannabis and pharmaceutical manufacturing.
Phase I laboratory investigation, Phase II manufacturing investigation, retesting rules and the four most common OOS citation patterns from recent inspections.
Quality agreements, CMO audit programmes and cGMP accountability for outsourced manufacturing - essential for cannabis tolling and white-label operations.
The mandatory annual data review required under both Health Canada GPP and FDA 21 CFR 211.180(e). Trend analysis, Cpk, supplier data and CAPA effectiveness.
Temperature controls, chain of custody documentation and the shipping records that cannabis inspectors evaluate when reviewing distribution compliance.
How to write a compliant response to a regulatory inspection observation. Applies directly to Health Canada compliance orders and FDA observations on cannabis facilities.
For cannabis producers manufacturing sterile cannabis oil for medical markets - the full Annex 1 2022 requirements for contamination control and environmental monitoring.
Every tool works for cannabis manufacturing. No login required. No subscription needed to try them.
Answer 10 questions about your role, facility type and inspection timeline. Get a personalised list of the courses your cannabis quality team needs most - in priority order.
Paste any regulation reference including Health Canada GPP clauses, Cannabis Regulations sections or FDA 21 CFR citations. Get a plain-language explanation of what it requires.
Describe your cannabis manufacturing deviation. Get a complete investigation framework covering scope, root cause methodology, CAPA structure and regulatory notification assessment.
Upload your cannabis SOP or paste the text. Get a structured gap analysis against 21 CFR, EU GMP or ICH standards with specific recommended language to add.
Enter your Health Canada compliance order or FDA observation details. Get a fully structured draft response covering all required sections. Copy to Word with one click.
"Cannabis manufacturers are being held to pharmaceutical standards. GMPify is the pharmaceutical training platform built to meet them."
27 years of live pharmaceutical GMP training experience. Every course built from primary regulatory sources - Health Canada GPP, FDA 21 CFR, EU GMP, ICH guidelines. Certificate on completion of every course. Full catalog access from day one.
Every plan includes full catalog access, all five AI tools and a certificate on every course.
Full catalog access for one learner. Everything included from day one.
Full catalog access for up to five team members. One subscription covers your quality team.
Two months free compared to monthly. Best value for individual learners.
Need training for a larger cannabis team? Contact us for enterprise pricing.
Try a free module before you commit to anything. Full catalog access from day one when you subscribe. No setup. No implementation. Just training that meets the standards cannabis regulators are applying.